RE:RE:RE:RE:RE:RE:RE:RE:Did anybody get some reply?
We probably will get another video in the new year, at least we should to clarify the situation.
Price is almost the same before the update so may be the deal is not completely dead. Then at this point insider buy could be a good support.
If the science is good (it is still not risk free as the clinical trials were missing) and nothing to worry for the product then insiders also should buy now. Any similar comments like "we are confident, no issue with science" is not trustable considering the whole process. They can not dictate what to do to the partner but they can easily put their own money in if what they claim is real. Some people here have millions of shares and it is fair to ask insiders to show some support. This is independent of a deal and doable, there is no reading between the lines or so for a news "all board members (+Green) bought 1M shares of each from the market". A buy from open market would increse the share price and would give investors more confidence to stay invested.
Do not forget there were more than one partners (if true) and it is not too realistic for both of them to leave the table in the last minute.